INSIGHTS ON CLINICAL TRIAL DESIGN

• How To Reduce Patient Dropout Rates In Clinical Trials

  Sponsors are addressing patient dropout rates by shifting from reactive troubleshooting to proactive protocol designs that minimize participant burden.

• Applying AI to Study Simulation: From Design to Analysis

  See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

• Improving Clinical Research Efficiency And Access For Underserved Populations

  Modernizing data workflows removes geographic barriers to clinical trials, ensuring rural patients access innovative care while reducing administrative burdens on dedicated research staff.

• Effective Study Design And Execution Of Renal And Hepatic Impairment Trials

  Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.

• Navigating The CrowdStrike Outage With Hybrid Meeting Solutions

  8/7/2024

  When the July 2024 CrowdStrike outage caused widespread disruptions to attendees' travel plans, Scout jumped into action with hybrid meeting solutions to rescue a rare disease Investigators' Meeting.

• Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?

  5/28/2026

  Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.

   

• Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial Recruitment

  10/27/2025

  Explore how collaboration between researchers and Patient Advocacy Groups (PAGs) can bridge the trust gap that undermines recruitment and can make trial participation more approachable and meaningful.

• Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM

  3/25/2026

  Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early. 

• GSK And Medable Discuss The Next Phase Of DCTs

  3/10/2025

  GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.